A Phase 1/2a Trial to Evaluate the Efficacy and the Safety of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3)
Phase of Trial: Phase I/II
Latest Information Update: 20 Apr 2016
At a glance
- Drugs Human papillomavirus vaccine (Primary)
- Indications Cervical intraepithelial neoplasia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Bioleaders Corporation
- 18 Apr 2016 Status changed from recruiting to completed.
- 12 Jan 2016 Planned End Date changed from 1 Mar 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
- 12 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Mar 2016, according to ClinicalTrials.gov record.